Recombinant Human Serum Albumin Market

Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.

Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.

Recombinant Human Serum Albumin Market contains market size and forecasts of Recombinant Human Serum Albumin in global, including the following market information:

Global Recombinant Human Serum Albumin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Recombinant Human Serum Albumin Market Sales, 2017-2022, 2023-2028, (Kg)

Global top five Recombinant Human Serum Albumin companies in 2021 (%)

The global Recombinant Human Serum Albumin market was valued at 72 million in 2021 and is projected to reach US$ 114.8 million by 2028, at a CAGR of 6.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

OsrHSA Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Human Serum Albumin include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen and HiMedia, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Recombinant Human Serum Albumin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Human Serum Albumin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Recombinant Human Serum Albumin Market Segment Percentages, by Type, 2021 (%)

OsrHSA

ScrHSA

Global Recombinant Human Serum Albumin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Recombinant Human Serum Albumin Market Segment Percentages, by Application, 2021 (%)

Cell Culture Media

Medical Supplements

Others

Global Recombinant Human Serum Albumin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)

Global Recombinant Human Serum Albumin Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Human Serum Albumin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Recombinant Human Serum Albumin revenues share in global market, 2021 (%)

Key companies Recombinant Human Serum Albumin sales in global market, 2017-2022 (Estimated), (Kg)

Key companies Recombinant Human Serum Albumin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Albumedix

Merck

Ventria (InVitria)

NCPC

Oryzogen

HiMedia